MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesis
Authors:
- Julien Masliah-PlanchonJMJulien Masliah-Planchon
- Eric PasmantEPEric Pasmant
- Armelle LuscanALArmelle Luscan
- Ingrid LaurendeauILIngrid Laurendeau
- Nicolas OrtonneNONicolas Ortonne
- Mikael HivelinMHMikael Hivelin
- Jennifer VarinJVJennifer Varin
- Laurence Valeyrie-AllanoreLVLaurence Valeyrie-Allanore
- Valérie DumaineVDValérie Dumaine
- Laurent LantieriLLLaurent Lantieri
- Karen LeroyKLKaren Leroy
- Béatrice ParfaitBPBéatrice Parfait
Open Access
- 13 July 2013
- journal article
- research article
- Published by Springer Nature in BMC Genomics
- Vol. 14 (1) , 473
Abstract
Background: Neurofibromatosis type 1 (NF1) is a common dominant tumor predisposition syndrome affecting 1 in 3,500 individuals. The hallmarks of NF1 are the development of peripheral nerve sheath tumors either benign (dermal and plexiform neurofibromas) or malignant (MPNSTs). Results: To comprehensively characterize the role of microRNAs in NF1 tumorigenesis, we analyzed 377 miRNAs expression in a large panel of dermal and plexiform neurofibromas, and MPNSTs. The most significantly upregulated miRNA in plexiform neurofibromas was miR-486-3p that targets the major tumor suppressor gene, PTEN. We confirmed PTEN downregulation at mRNA level. In plexiform neurofibromas, we also report aberrant expression of four miRNAs involved in the RAS-MAPK pathway (miR-370, miR-143, miR-181a, and miR-145). In MPNSTs, significant deregulated miRNAs were involved in PTEN repression (miR-301a, miR-19a, and miR-106b), RAS-MAPK pathway regulation (Let-7b, miR-195, and miR-10b), mesenchymal transition (miR-200c, let-7b, miR-135a, miR-135b, and miR-9), HOX genes expression (miR-210, miR-196b, miR-10a, miR-10b, and miR-9), and cell cycle progression (miR-195, let-7b, miR-20a, miR-210, miR-129-3p, miR-449a, and miR-106b). Conclusion: We confirmed the implication of PTEN in genesis of plexiform neurofibromas and MPNSTs in NF1. Markedly deregulated miRNAs might have potential diagnostic or prognostic value and could represent novel strategies for effective pharmacological therapies of NF1 tumors.Keywords
This publication has 51 references indexed in Scilit:
- Role of Noncoding RNA ANRIL in Genesis of Plexiform Neurofibromas in Neurofibromatosis Type 1JNCI: Journal of the National Cancer Institute, 2011
- Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486Proceedings of the National Academy of Sciences, 2010
- Differential Expression ofCCN1/CYR61,CCN3/NOV,CCN4/WISP1, andCCN5/WISP2in Neurofibromatosis Type 1 TumorigenesisJournal of Neuropathology & Experimental Neurology, 2010
- PTEN dosage is essential for neurofibroma development and malignant transformationProceedings of the National Academy of Sciences, 2009
- Genome‐wide transcriptome analyses reveal p53 inactivation mediated loss of miR‐34a expression in malignant peripheral nerve sheath tumoursThe Journal of Pathology, 2009
- Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1Human Molecular Genetics, 2009
- High-Resolution DNA Copy Number Profiling of Malignant Peripheral Nerve Sheath Tumors Using Targeted Microarray-Based Comparative Genomic HybridizationClinical Cancer Research, 2008
- Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCRMolecular Cancer, 2004
- Mouse Tumor Model for Neurofibromatosis Type 1Science, 1999
- The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14Cell, 1993